IS WEGOVY® PEN RIGHT FOR ME?
Find out how Wegovy® pen for adults with obesity, or with overweight and at least one weight-related medical problem, along with a reduced-calorie diet and increased physical activity, can help you lose weight and keep it off.
Jump to:
The results speak for themselves. Here's what the data says:
In a 72-week medical study of 1,407 adults living with obesity, along with a reduced-calorie diet and increased physical activity: Adults taking Wegovy® HD pen lost an average of 19% body weight (~47 lb) compared to people taking placebo (not on medicine) who lost 4% (~10 lb). 89% of adults taking Wegovy® HD lost 5% or more weight compared with 38% taking placebo.
See Wegovy® HD pen study details here.
Curious about your potential weight loss with Wegovy® HD pen?
Calculate it here.
In the same study
31% of adults taking Wegovy® HD lost 25% or more weight compared with 0% of adults on placebo.
Individual results may vary.
Wegovy® HD study details
Results are from a 72-week medical study of 1,407 adults with obesity (BMI ≥30 kg/m2). Adults with type 2 diabetes were excluded. Patients were taking either Wegovy® HD pen, Wegovy® 2.4 mg pen, or placebo. All groups received instruction for a reduced-calorie diet and increased physical activity. During the trial, 12% of participants taking Wegovy® HD discontinued treatment compared with 29% taking placebo.
BMI=body mass index.
Weight loss results with Wegovy® 2.4 mg pen
In a 68-week medical study of 1,961 adults with obesity, or with overweight and at least one weight-related medical problem, along with a reduced-calorie diet and increased physical activity:
Adults who used Wegovy® 2.4 mg pen achieved on average 15% weight loss
Adults who took placebo achieved on average ~2.5% weight loss (~6 lb) based on a 232 lb starting weight. 83% of adults using Wegovy® 2.4 mg pen lost 5% or more weight compared with 31% taking placebo.
Benefits beyond the scale
While not approved to treat these conditions, adults using Wegovy® 2.4 mg pen experienced improvements in:
WAIST SIZE
BLOOD PRESSURE
CHOLESTEROL
BLOOD SUGAR
Some adults using Wegovy® experienced an increase in resting heart rate.
Results are from a 68-week medical study of 1,961 adults with obesity (BMI ≥30 kg/m2), or with overweight (BMI ≥27 kg/m2) and at least one weight-related medical problem, including high blood pressure or high cholesterol. Adults with type 2 diabetes were excluded. Patients were taking either Wegovy® 2.4 mg pen or placebo. Both groups received instruction for a reduced-calorie diet and increased physical activity. During the trial, 17% of participants taking Wegovy® discontinued treatment compared with 22% taking placebo.
BMI=body mass index.
Learn more about Wegovy® pen for weight loss
GETTING WEGOVY®
FOR A WEEKLY ROUTINE
Remember, if it’s not made by Novo Nordisk®, it’s not FDA-approved Wegovy®.
Your healthcare professional will determine the dose that's right for you and make any needed adjustments. Always follow the detailed instructions provided by your healthcare professional and in the Instructions for use, including specific timing and food considerations.
FDA=Food and Drug Administration.
FAQs about Wegovy® pen
With a maintenance dose of 2.4 mg: In a medical study, adults living with obesity, or with overweight and at least one weight-related medical problem, who used Wegovy® 2.4 mg pen, along with a reduced-calorie diet and increased physical activity, lost ~35 lb, or on average 15% of their starting body weight. In comparison, adults who used placebo lost ~6 lb, or on average about 2.5% of their body weight. The average starting weight for both groups was 232 lb.
83% or about 8 in 10 adults achieved 5% or more weight loss with Wegovy® 2.4 mg pen compared with 31% taking placebo.*
*Results are from a 68-week medical study of 1,961 adults with obesity (BMI ≥30 kg/m2), or with overweight (BMI ≥27 kg/m2) and at least one weight-related medical problem, including high blood pressure or high cholesterol. Adults with type 2 diabetes were excluded. Patients were taking either Wegovy® 2.4 mg pen or placebo. Both groups received instruction for a reduced-calorie diet and increased physical activity. During the trial, 17% of participants taking Wegovy® discontinued treatment compared with 22% taking placebo.
With a maintenance dose of Wegovy® HD (semaglutide) injection 7.2 mg: In a medical study, adults living with obesity who used Wegovy® 7.2 mg pen, along with a reduced-calorie diet and increased physical activity, lost ~47 lb, or on average 19% of their starting body weight. In comparison, adults who used placebo lost ~10 lb, or on average 4% of their body weight. The average starting weight for both groups was 248 lb.
About 1 in 3 adults achieved 25% or more weight loss, ~62 lb based on a 248 lb starting weight.†
†Results are from a 72-week medical study of 1,407 adults with obesity (BMI ≥30 kg/m2). Adults with type 2 diabetes were excluded. Patients were taking Wegovy® injection 7.2 mg, Wegovy® injection 2.4 mg, or placebo. All groups received instruction for a reduced-calorie diet and increased physical activity. During the trial, 12% of participants taking Wegovy® injection 7.2 mg discontinued treatment compared with 29% taking placebo.
BMI=body mass index.
People respond to medication, including Wegovy®, differently, so there is no set time when you can expect to see results with Wegovy®. Ask your healthcare professional about what might be realistic for you.
Wegovy® HD (7.2 mg) may be an option for adults who are looking to lose additional weight after being on the 2.4 mg dose for at least 4 weeks. Talk to your doctor about whether stepping up to a higher dose could be right for you.
Wegovy® HD is a higher dose of semaglutide, the same active ingredient that’s in the Wegovy® 2.4 mg pen. It is a single-dose pen, just like other Wegovy® once-weekly injections. Like all forms of Wegovy® (pill or pen), Wegovy® HD is used along with a reduced-calorie diet and increased physical activity to help you lose weight and keep it off.
The Wegovy® (semaglutide) pen is a prefilled, single-use pen used to deliver a once-weekly semaglutide injection for weight management. The pen contains a hidden needle and is preset with the prescribed dose. Patients should follow the Instructions for Use and guidance from their healthcare professional when administering Wegovy®.
Yes, unused Wegovy® pens should be stored in the refrigerator between 36 °F to 46 °F (2 °C to 8 °C). Wegovy® pens can also be kept at room temperature (46 °F to 86 °F) before removing the pen cap and in the original carton for up to 28 days.
If you miss a dose of your Wegovy® injection and there are more than 2 days until your next scheduled dose, take the missed dose as soon as you remember. If it's less than 2 days, skip the missed dose and take your next dose on the regularly scheduled day. If you miss doses of Wegovy® for 2 or more weeks, take your next dose on the regularly scheduled day or call your healthcare professional to talk about how to restart your treatment.
No, each Wegovy® pre-filled pen contains one dose of semaglutide and is designed for single use. It should be properly disposed of after each weekly injection.
Become a WEGOVY® INSIDER
Wondering if the Wegovy® pen is right for you? You don’t have to figure it out alone. Let us help you find the option that fits your lifestyle.
Important Safety Information
What is the most important information I should know about Wegovy®?
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Do not use Wegovy® if:
- you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets. See symptoms of serious allergic reaction in “What are the possible side effects of Wegovy®?”
Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:
- have or have had problems with your pancreas or kidneys
- have type 2 diabetes and a history of diabetic retinopathy
- are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)
- are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant
- are breastfeeding or plan to breastfeed. Breastfeeding is not recommended during treatment with Wegovy® tablets. It is not known if Wegovy® when received through an injection passes into your breast milk
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
What are the possible side effects of Wegovy®?
Wegovy® may cause serious side effects, including:
- inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back
- gallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools
- increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery
- dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away
- severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go away
- serious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat
- change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy®
- increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes
- food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, changes in skin sensations, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and hair loss.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
What is Wegovy?®
Wegovy® (semaglutide) injection and Wegovy® (semaglutide) tablets are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® (semaglutide) injection and Wegovy® (semaglutide) tablets are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Important Safety Information
What is the most important information I should know about Wegovy®?
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Do not use Wegovy® if:
- you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets. See symptoms of serious allergic reaction in “What are the possible side effects of Wegovy®?”
Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:
- have or have had problems with your pancreas or kidneys
- have type 2 diabetes and a history of diabetic retinopathy
- are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)
- are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant
- are breastfeeding or plan to breastfeed. Breastfeeding is not recommended during treatment with Wegovy® tablets. It is not known if Wegovy® when received through an injection passes into your breast milk
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
What are the possible side effects of Wegovy®?
Wegovy® may cause serious side effects, including:
- inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back
- gallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools
- increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery
- dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away
- severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go away
- serious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat
- change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy®
- increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes
- food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, changes in skin sensations, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and hair loss.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
What is Wegovy?®
Wegovy® (semaglutide) injection and Wegovy® (semaglutide) tablets are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.